# Dhamasa (Fagonia indica)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/dhamasa-fagonia-indica
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-06
**Evidence Score:** 1 / 10
**Category:** Middle Eastern
**Also Known As:** Fagonia indica Burm.f., Dhamasa, Dhamaso, Shauka-e-Bayza, Dhamah, Virgata Fagonia, Damahan

## Overview

Fagonia indica contains bioactive flavonoids (including quercetin and kaempferol), saponins, alkaloids, and terpenoids that exert antioxidant, anti-inflammatory, and cytotoxic effects by inhibiting NF-κB signaling, scavenging [reactive oxygen species](/ingredients/condition/antioxidant), and modulating [pro-inflammatory cytokine](/ingredients/condition/inflammation) production. Preclinical studies have demonstrated [hepatoprotective](/ingredients/condition/detox) activity, significant reduction in malondialdehyde levels as a marker of oxidative stress, and selective antiproliferative effects against human breast cancer cell lines at IC50 values in the low microgram-per-milliliter range.

## Health Benefits

- **Blood Purification and Detoxification**: Traditionally used in Unani and Ayurvedic medicine as a blood purifier (musaffi-e-khun), the plant's saponins and flavonoids support hepatic detoxification pathways, enhancing clearance of metabolic waste products and reducing systemic oxidative burden.
- **Anticancer and Antiproliferative Activity**: Ethanolic and aqueous extracts of Fagonia indica have shown cytotoxic activity against breast, cervical, and liver cancer cell lines in vitro, with the flavonoid and saponin fractions inducing apoptosis and inhibiting cell cycle progression.
- **[Anti-inflammatory](/ingredients/condition/inflammation) Effects**: Triterpenoid saponins and phenolic compounds in Fagonia indica suppress prostaglandin synthesis and reduce levels of TNF-α and IL-6 in preclinical models, contributing to its traditional use in joint pain and fever management.
- **[Hepatoprotective](/ingredients/condition/detox) Activity**: Aqueous extracts have demonstrated liver-protective effects in carbon tetrachloride-induced hepatotoxicity models in rodents, reducing serum ALT and AST levels and preserving hepatic architecture by attenuating lipid peroxidation.
- **Antioxidant Capacity**: The plant exhibits strong free radical scavenging activity in DPPH and ABTS assays, attributed primarily to its quercetin, kaempferol, and rutin content, which chelate transition metals and neutralize [reactive oxygen species](/ingredients/condition/antioxidant).
- **[Antimicrobial](/ingredients/condition/immune-support) Properties**: Methanolic extracts have shown inhibitory activity against Staphylococcus aureus, Escherichia coli, and Candida albicans in disc diffusion assays, with minimum inhibitory concentrations in the range of 0.5–2 mg/mL, suggesting potential utility in managing infections.
- **Antidiabetic Potential**: Preliminary studies in streptozotocin-induced diabetic rodent models indicate that Fagonia indica extracts reduce fasting blood glucose and improve [insulin sensitivity](/ingredients/condition/weight-management), potentially through inhibition of α-glucosidase and α-amylase enzymes.

## Mechanism of Action

The primary bioactive constituents of Fagonia indica — including flavonoids (quercetin, kaempferol, rutin), triterpenoid saponins, and alkaloids — exert their pharmacological effects through multiple complementary molecular mechanisms. Quercetin and kaempferol inhibit the NF-κB transcription factor pathway by preventing IκB phosphorylation and degradation, thereby suppressing downstream expression of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s (TNF-α, IL-1β, IL-6) and cyclooxygenase-2 (COX-2). Saponin fractions disrupt membrane integrity of cancer cells and microorganisms, trigger mitochondria-mediated apoptosis via cytochrome c release and caspase-3/9 activation, and inhibit the PI3K/Akt/mTOR signaling cascade that drives tumor cell survival. [Antioxidant activity](/ingredients/condition/antioxidant) is mediated through direct ROS scavenging, upregulation of endogenous antioxidant enzymes (superoxide dismutase, catalase, [glutathione](/ingredients/condition/detox) peroxidase), and chelation of redox-active iron and copper ions that would otherwise catalyze hydroxyl radical formation.

## Clinical Summary

No registered phase II or phase III clinical trials have been published evaluating Fagonia indica in human subjects for any indication as of current knowledge. The most clinically relevant preclinical data come from rodent [hepatoprotect](/ingredients/condition/detox)ion studies in which oral administration of aqueous extract at 200–400 mg/kg body weight significantly reduced CCl4-induced elevations in ALT and AST, and from in vitro antiproliferative assays against MCF-7 breast cancer cells with IC50 values reported between 12 and 75 μg/mL depending on the extraction method. Ethnopharmacological surveys in Pakistan and the Middle East document widespread traditional use for fever, skin diseases, and cancer-like symptoms, providing a strong rationale for clinical investigation but not constituting clinical evidence of efficacy. Confidence in results for human applications must therefore be rated as low, pending well-designed randomized controlled trials with validated endpoints.

## Nutritional Profile

Fagonia indica aerial parts contain modest levels of crude protein (approximately 8–12% dry weight), crude fiber (20–30% dry weight), and ash (10–15% dry weight) reflecting its mineral content from arid soils including calcium, potassium, and magnesium. The primary pharmacologically relevant phytochemicals include flavonoids — quercetin, kaempferol, and rutin quantified in various studies at 0.5–3% of dry extract weight — as well as triterpenoid saponins, sterols (β-sitosterol, stigmasterol), alkaloids (harmine-related compounds reported in some analyses), and phenolic acids including gallic acid and chlorogenic acid. Vitamin C and carotenoids are present at low concentrations consistent with its arid-adapted physiology. Bioavailability of flavonoid aglycones is generally higher than their glycosidic forms; gut microbiota deglycosylation plays an important role in activating quercetin and kaempferol glycosides present in the plant.

## Dosage & Preparation

- **Traditional Herbal Tea (Decoction)**: 5–10 grams of dried aerial parts (stems, leaves, flowers) boiled in 200–300 mL water for 10–15 minutes, strained and consumed 1–2 times daily; this is the most common traditional method in Pakistan and the Middle East.
- **Aqueous Extract (Cold Infusion)**: Dried herb soaked overnight in cold water (5 g per 250 mL) and consumed as a blood purifier in Unani medicine, typically in the morning on an empty stomach.
- **Powdered Herb (Churna)**: 1–3 grams of dried and ground Fagonia indica powder mixed with water or honey, taken 2 times daily; dose used in Ayurvedic and Unani compounding.
- **Ethanolic or Methanolic Extract (Research Context)**: Standardized extracts used in preclinical studies at 200–400 mg/kg in rodents; no human-validated standardized extract dosage is established.
- **Standardization**: No internationally recognized standardization percentage for flavonoid or saponin content is currently established for commercial preparations.
- **Timing Note**: Traditional use recommends consumption before meals for digestive and detoxification applications; no clinical timing data exist for other indications.

## Safety & Drug Interactions

Fagonia indica is generally consumed at low doses in traditional settings without widespread reports of acute toxicity; however, systematic human safety data are lacking, and the herb should be regarded as insufficiently characterized from a clinical toxicology standpoint. Animal studies using high-dose extracts (above 1000 mg/kg in rodents) have not reported overt organ toxicity, but chronic exposure studies and genotoxicity assessments in humans are not available in published literature. Potential drug interactions are theorized based on its known CYP450 enzyme-modulating flavonoid content, suggesting caution when co-administered with anticoagulants (warfarin), immunosuppressants (cyclosporine), or chemotherapeutic agents, though no human pharmacokinetic interaction studies have been conducted. Fagonia indica is contraindicated in pregnancy due to the presence of saponins with potential uterotonic activity reported in traditional texts, and use during lactation is not recommended due to absence of safety data; individuals with autoimmune conditions or on hepatic medications should consult a physician before use.

## Scientific Research

The evidence base for Fagonia indica consists predominantly of in vitro cell culture studies and in vivo rodent model experiments, with no published large-scale randomized controlled trials in humans as of the available literature. Multiple Pakistani and Indian research groups have published phytochemical characterization studies and bioassay-guided fractionation work confirming the presence of active flavonoids and saponins with measurable cytotoxic and [antioxidant activity](/ingredients/condition/antioxidant); however, human clinical data remain extremely limited. A small number of observational and ethnobotanical reports document traditional use in cancer patients in Pakistan who self-administer Fagonia indica tea, prompting interest from UK and Pakistani researchers, though formal phase I or phase II clinical trials have not been publicly completed or published with full datasets. The overall evidence strength is preclinical, meaning efficacy signals are promising but cannot yet be translated into confirmed clinical recommendations for humans.

## Historical & Cultural Context

Fagonia indica, known as Dhamasa or Dhamaso in Urdu and Hindi, has been used for centuries in Unani, Ayurvedic, and traditional Arab medicine as a blood purifier, antipyretic, and treatment for skin diseases, liver disorders, and [inflammatory](/ingredients/condition/inflammation) conditions. In the classical Unani pharmacopeia, it is classified as a drug with cold and dry temperament (mizaj), prescribed for heat-related illnesses, excessive thirst, and toxic blood conditions. The plant holds particular cultural prominence in Pakistan and northwestern India, where it is popularly believed to possess anticancer properties and is consumed as a tea by patients seeking alternative or complementary cancer therapy, a practice that drew the attention of British researchers in the early 2000s. Dhamasa is also referenced in medieval Arabic medical texts and is used in traditional Iranian medicine (Tibb-e-Sunnati) under the name Shauka-e-Bayza for treating skin eruptions, fevers, and venomous bites.

## Synergistic Combinations

In traditional Unani formulations, Fagonia indica is frequently combined with Tinospora cordifolia (Guduchi) and Azadirachta indica (Neem) to enhance blood purification and [immunomodulatory](/ingredients/condition/immune-support) effects, with the combination theorized to produce additive [anti-inflammatory](/ingredients/condition/inflammation) and [hepatoprotective](/ingredients/condition/detox) activity through complementary NF-κB and TLR4 pathway modulation. Pairing with Curcuma longa (turmeric) is rationalized by the shared flavonoid-mediated COX-2 inhibition and ROS scavenging mechanisms, potentially producing synergistic anti-inflammatory outcomes. Some practitioners also combine Dhamasa with Glycyrrhiza glabra (licorice root) to improve palatability and add additional anti-inflammatory triterpenoid content, though no controlled trials have formally evaluated any of these combinations in humans.

## Frequently Asked Questions

### What is Fagonia indica used for in traditional medicine?

In Unani and Ayurvedic medicine, Fagonia indica (Dhamasa) has been used for centuries as a blood purifier, antipyretic, and treatment for liver disorders, skin diseases, and inflammatory conditions. It is most commonly prepared as a decoction by boiling 5–10 grams of dried aerial parts in water and is traditionally consumed to clear toxins from the blood and reduce fever. In Pakistan and parts of the Middle East, it is also self-administered by some cancer patients as a complementary therapy, prompting ongoing scientific investigation into its antiproliferative properties.

### Does Fagonia indica have anticancer properties?

In vitro studies have shown that ethanolic and aqueous extracts of Fagonia indica inhibit the proliferation of human breast cancer (MCF-7), cervical cancer, and liver cancer cell lines, with reported IC50 values between 12 and 75 μg/mL depending on the extraction method used. The mechanism appears to involve flavonoid- and saponin-mediated apoptosis through caspase-3/9 activation and disruption of the PI3K/Akt/mTOR survival pathway. However, these findings are exclusively preclinical, and no human clinical trials have confirmed anticancer efficacy or safety in cancer patients.

### What are the main active compounds in Fagonia indica?

The primary bioactive constituents of Fagonia indica include flavonoids — notably quercetin, kaempferol, and rutin — along with triterpenoid saponins, alkaloids, β-sitosterol, and phenolic acids such as gallic acid and chlorogenic acid. The flavonoid content has been quantified at approximately 0.5–3% of dry extract weight in various studies. These compounds collectively contribute to the plant's antioxidant, anti-inflammatory, antimicrobial, and cytotoxic activities observed in laboratory research.

### Is Fagonia indica safe to consume, and are there any drug interactions?

Fagonia indica is widely consumed in traditional settings without widespread reports of acute harm, but formal human safety and toxicology studies are very limited. Based on its flavonoid content, it theoretically has the potential to interact with anticoagulants like warfarin, immunosuppressant drugs such as cyclosporine, and certain chemotherapy agents by modulating CYP450 enzymes. The herb is not recommended during pregnancy due to potential uterotonic effects of its saponin content, and individuals on prescription medications should consult a healthcare provider before use.

### How is Dhamasa (Fagonia indica) prepared as a tea?

The most common traditional preparation is a decoction made by boiling 5–10 grams of dried Fagonia indica aerial parts — including stems, leaves, and flowers — in 200–300 mL of water for 10–15 minutes, then straining and drinking the liquid 1–2 times per day. Some traditional practitioners recommend a cold infusion instead, soaking the dried herb overnight in cold water and consuming it in the morning on an empty stomach for blood purification purposes. No clinically validated standardized dosage exists for humans, so these traditional doses are used empirically based on historical practice.

### What is the difference between Dhamasa and other traditional blood purifiers like Neem or Turmeric?

While Neem and Turmeric are well-known liver supporters, Dhamasa (Fagonia indica) is uniquely rich in saponins and specific flavonoid compounds that target both hepatic detoxification and systemic oxidative stress simultaneously. Dhamasa has demonstrated distinct antiproliferative mechanisms in research, particularly against cancer cell lines, whereas Neem and Turmeric primarily excel in antimicrobial and anti-inflammatory roles. The choice between them depends on whether the primary goal is comprehensive detoxification (Dhamasa) versus targeted immune or inflammation support (Neem/Turmeric).

### Who should avoid Dhamasa (Fagonia indica) supplementation?

Individuals with bleeding disorders, those taking anticoagulant medications, and pregnant or nursing women should avoid Dhamasa until further safety data is available, as saponins can affect platelet function and the herb's safety profile during pregnancy has not been established. People with severe liver or kidney disease should consult a healthcare provider before use, as detoxification herbs may place additional burden on compromised organs. Additionally, those with known allergies to plants in the Zygophyllaceae family should exercise caution.

### How strong is the current clinical evidence for Dhamasa's anticancer and detoxification claims?

While in vitro and animal studies show promising antiproliferative activity and hepatic support mechanisms, human clinical trials on Dhamasa remain limited, making evidence strength moderate rather than conclusive. Most research has focused on ethanolic and aqueous extracts in laboratory settings, with far fewer peer-reviewed human studies validating traditional dosing or long-term efficacy. Current evidence supports further investigation but should not be interpreted as a replacement for conventional cancer treatment or proven detoxification therapies.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*